Noble Financial Reaffirms Their Buy Rating on Kratos Defense

By Jason Carr

In a report released yesterday, Mark Jordan from Noble Financial reiterated a Buy rating on Kratos Defense (NASDAQ: KTOS). The company’s shares opened today at $11.93.

According to TipRanks.com, Jordan is a 3-star analyst with an average return of 3.6% and a 62.0% success rate. Jordan covers the Healthcare sector, focusing on stocks such as ContraVir Pharmaceuticals Inc, Adamas Pharmaceuticals, and Corbus Pharmaceuticals.

Currently, the analyst consensus on Kratos Defense is Strong Buy and the average price target is $14.57, representing a 22.1% upside.

In a report issued on September 6, B. Riley also assigned a Buy rating to the stock with a $16 price target.

Based on Kratos Defense’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $186 million and GAAP net loss of $6.2 million. In comparison, last year the company earned revenue of $168 million and had a GAAP net loss of $10.4 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Kratos Defense & Security Solutions, Inc. provides mission critical products, services and solutions for United States national security priorities. It operates through the following segments: Kratos Government Solutions, Unmanned Systems, and Public Safety & Security.